163 related articles for article (PubMed ID: 30206007)
1. Intrauterine growth restriction and later cardiovascular function.
Crispi F; Crovetto F; Gratacos E
Early Hum Dev; 2018 Nov; 126():23-27. PubMed ID: 30206007
[TBL] [Abstract][Full Text] [Related]
2. Postnatal persistence of cardiac remodeling and dysfunction in late fetal growth restriction.
Crispi F; Crovetto F; Rodriguez-López M; Sepúlveda-Martinez Á; Miranda J; Gratacós E
Minerva Obstet Gynecol; 2021 Aug; 73(4):471-481. PubMed ID: 33949826
[TBL] [Abstract][Full Text] [Related]
3. Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction.
Cruz-Lemini M; Crispi F; Valenzuela-Alcaraz B; Figueras F; Sitges M; Bijnens B; Gratacós E
Ultrasound Obstet Gynecol; 2016 Sep; 48(3):349-56. PubMed ID: 26415719
[TBL] [Abstract][Full Text] [Related]
4. Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease.
Crispi F; Miranda J; Gratacós E
Am J Obstet Gynecol; 2018 Feb; 218(2S):S869-S879. PubMed ID: 29422215
[TBL] [Abstract][Full Text] [Related]
5. Human fetal growth restriction: a cardiovascular journey through to adolescence.
Sehgal A; Skilton MR; Crispi F
J Dev Orig Health Dis; 2016 Dec; 7(6):626-635. PubMed ID: 27384077
[TBL] [Abstract][Full Text] [Related]
6. A fetal cardiovascular score to predict infant hypertension and arterial remodeling in intrauterine growth restriction.
Cruz-Lemini M; Crispi F; Valenzuela-Alcaraz B; Figueras F; Gómez O; Sitges M; Bijnens B; Gratacós E
Am J Obstet Gynecol; 2014 Jun; 210(6):552.e1-552.e22. PubMed ID: 24368136
[TBL] [Abstract][Full Text] [Related]
7. Different etiologies of intrauterine growth restriction and different consistencies in the occurrence of abnormal local nonstationarity of fetal heart rate.
Yum MK; Kim CR; Park EY; Kim JH; Park KJ
Clin Exp Hypertens; 2006 Feb; 28(2):147-56. PubMed ID: 16546840
[TBL] [Abstract][Full Text] [Related]
8. Fetal growth restriction results in remodeled and less efficient hearts in children.
Crispi F; Bijnens B; Figueras F; Bartrons J; Eixarch E; Le Noble F; Ahmed A; Gratacós E
Circulation; 2010 Jun; 121(22):2427-36. PubMed ID: 20497977
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular adaptation to extrauterine life after intrauterine growth restriction.
Rodriguez-Guerineau L; Perez-Cruz M; Gomez Roig MD; Cambra FJ; Carretero J; Prada F; Gómez O; Crispi F; Bartrons J
Cardiol Young; 2018 Feb; 28(2):284-291. PubMed ID: 29081323
[TBL] [Abstract][Full Text] [Related]
10. Prenatal Mechanistic Target of Rapamycin Complex 1 (m TORC1) Inhibition by Rapamycin Treatment of Pregnant Mice Causes Intrauterine Growth Restriction and Alters Postnatal Cardiac Growth, Morphology, and Function.
Hennig M; Fiedler S; Jux C; Thierfelder L; Drenckhahn JD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28778941
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of intrauterine growth restriction: cardiovascular disorders.
Demicheva E; Crispi F
Fetal Diagn Ther; 2014; 36(2):143-53. PubMed ID: 23948759
[TBL] [Abstract][Full Text] [Related]
12. Fetal growth restriction and cardiovascular outcome in early human infancy: a prospective longitudinal study.
Mäkikallio K; Shah J; Slorach C; Qin H; Kingdom J; Keating S; Kelly E; Manlhiot C; Redington A; Jaeggi E
Heart Vessels; 2016 Sep; 31(9):1504-13. PubMed ID: 26386571
[TBL] [Abstract][Full Text] [Related]
13. Early origins of adult disease: low birth weight and vascular remodeling.
Visentin S; Grumolato F; Nardelli GB; Di Camillo B; Grisan E; Cosmi E
Atherosclerosis; 2014 Dec; 237(2):391-9. PubMed ID: 25463063
[TBL] [Abstract][Full Text] [Related]
14. Developmental programming of cardiovascular disease following intrauterine growth restriction: findings utilising a rat model of maternal protein restriction.
Zohdi V; Lim K; Pearson JT; Black MJ
Nutrients; 2014 Dec; 7(1):119-52. PubMed ID: 25551250
[TBL] [Abstract][Full Text] [Related]
15. Cord Blood Biomarkers of Cardiac Dysfunction and Damage in Term Growth-Restricted Fetuses Classified by Severity Criteria.
Perez-Cruz M; Crispi F; Fernández MT; Parra JA; Valls A; Gomez Roig MD; Gratacós E
Fetal Diagn Ther; 2018; 44(4):271-276. PubMed ID: 29190628
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of myocardial tissue Doppler vs conventional echocardiography in the evaluation of cardiac dysfunction in early-onset intrauterine growth restriction.
Comas M; Crispi F; Cruz-Martinez R; Martinez JM; Figueras F; Gratacós E
Am J Obstet Gynecol; 2010 Jul; 203(1):45.e1-7. PubMed ID: 20451892
[TBL] [Abstract][Full Text] [Related]
17. Persistence of Cardiac Remodeling in Preadolescents With Fetal Growth Restriction.
Sarvari SI; Rodriguez-Lopez M; Nuñez-Garcia M; Sitges M; Sepulveda-Martinez A; Camara O; Butakoff C; Gratacos E; Bijnens B; Crispi F
Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28093413
[TBL] [Abstract][Full Text] [Related]
18. Fetal programming of cardiac function and disease.
Meyer K; Lubo Zhang
Reprod Sci; 2007 Apr; 14(3):209-16. PubMed ID: 17636233
[TBL] [Abstract][Full Text] [Related]
19. Fetal cardiac function in late-onset intrauterine growth restriction vs small-for-gestational age, as defined by estimated fetal weight, cerebroplacental ratio and uterine artery Doppler.
Pérez-Cruz M; Cruz-Lemini M; Fernández MT; Parra JA; Bartrons J; Gómez-Roig MD; Crispi F; Gratacós E
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):465-71. PubMed ID: 26112274
[TBL] [Abstract][Full Text] [Related]
20. Perinatal heart programming: long-term consequences.
Faa A; Ambu R; Faa G; Fanos V
Curr Med Chem; 2014; 21(27):3165-72. PubMed ID: 24606508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
